MeridStreet Open terminal →
MARKET MOVES

Bonus issue alert! Last day to buy this Rakesh Jhunjhunwala-backed smallcap pharma stock for 1:1 bonus bonanza

·Economic Times·Impact 1/5 · Low
MeridStreet AI summary

Investors are racing against time to buy a small-cap pharma stock backed by the late Rakesh Jhunjhunwala, as today marks the last day to qualify for a 1:1 bonus issue. This means that investors who purchase the stock today will receive an additional share for every one they own, potentially increasing their returns. The bonus issue is a significant development for the company and its shareholders, and buying the stock now could be a lucrative opportunity for those who act quickly.

Source reporting

Read the source report: Economic Times →

MeridStreet analysis

Why it matters

The bonus issue is a corporate event, and investors need to purchase shares before the record date to be eligible. This does not indicate a change in market sentiment or direction.

Market impact

Impact score
1 / 5
Market signal
Neutral
Category
Market moves
Model confidence
50%

Transmission channels

Bonus issue announcement→Share purchase→Record date→Bonus issue

Explore the intelligence

Live news feed
Real-time global markets, trade & geopolitics
All stories
Every tracked story cluster
Global macro
GDP, inflation & policy rates across major economies
Open the live MeridStreet terminal →

MeridStreet does not reproduce source articles. The summary and analysis above are generated by MeridStreet from public headlines and its own market model; the original reporting belongs to Economic Times. For information only — not financial advice.